{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:39:28Z","timestamp":1792082368892,"version":"4.4.0"},"reference-count":186,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.4065\/75.7.711","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:17:28Z","timestamp":1232759848000},"page":"711-721","source":"Crossref","is-referenced-by-count":64,"title":["Methylphenidate: Its Pharmacology and Uses"],"prefix":"10.4065","volume":"75","author":[{"given":"Thomas D.","family":"Challman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Lipsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/75.7.711_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/15563659709001195","article-title":"Analeptic use in clinical toxicology: a historical appraisal","volume":"35","author":"Wax","year":"1997","journal-title":"J Toxicol Clin Toxicoi"},{"key":"10.4065\/75.7.711_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2307\/3528571","article-title":"The run on Ritalin: attention deficit disorder and stimulant treatment in the 1990s","volume":"26","author":"Diller","year":"1996","journal-title":"Hastings Cen Rep"},{"key":"10.4065\/75.7.711_bib3","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1542\/peds.98.6.1084","article-title":"Increased methylphenidate usage for attention deficit disorder in the 1990s","volume":"98","author":"Safer","year":"1996","journal-title":"Pediatrics"},{"key":"10.4065\/75.7.711_bib4","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJM199903113401007","article-title":"Treatment of atlention-deficit-hypcractivity disorder","volume":"340","author":"Elia","year":"1999","journal-title":"N F.ngU Med"},{"key":"10.4065\/75.7.711_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJM199901073400107","article-title":"Problems in the management of attention-deficit-hyperactivity disorder","volume":"340","author":"Zametkin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.4065\/75.7.711_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003495-199856020-00005","article-title":"Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder [published correction appears in Drugs. 1999;58:597]","volume":"56","author":"Cyr","year":"1998","journal-title":"Drugs"},{"issue":"suppl 7","key":"10.4065\/75.7.711_bib7","first-page":"42","article-title":"Psychopharmacology of ADHD: children and adolescents","volume":"59","author":"Findling","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib8","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jama.279.14.1100","article-title":"Council on Scientific Affairs. American Medical Association. Diagnosis and treatment of attention-deficit\/hypcractivity disorder in children and adolescents","volume":"279","author":"Goldman","year":"1998","journal-title":"JAMA"},{"key":"10.4065\/75.7.711_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.mp.4000421","article-title":"Anti-hypcraclivily medication: melhyl-phcnidatc and amphetamine","volume":"3","author":"Seeman","year":"1998","journal-title":"Mol Psychiatry"},{"key":"10.4065\/75.7.711_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0193-953X(05)70304-X","article-title":"Use of stimulante in the medically ill","volume":"19","author":"Masand","year":"1996","journal-title":"Psychiair Clin North Am"},{"key":"10.4065\/75.7.711_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-2952(61)90100-9","article-title":"Investigations into the correlations hetween monoamine oxidase inhibition and other effects due to methylphcnydate and its slercoisomcrs","volume":"8","author":"Szporny","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"10.4065\/75.7.711_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s002130050267","article-title":"Chiral drugs: comparison of the pharmacokinctics of Cd-threo and L-three-methyl-phenidate in the human and baboon brain","volume":"131","author":"Ding","year":"1997","journal-title":"Psyckopharmacotogy (Berit"},{"key":"10.4065\/75.7.711_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0022-3565(25)30172-2","article-title":"Blockade by reserpine of methylphenidate-induced release of brain dopamine","volume":"193","author":"Chiuch","year":"1975","journal-title":"J Pharmacol Fath Ther"},{"key":"10.4065\/75.7.711_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-3565(25)29222-9","volume":"181","author":"Ferris","year":"1972","journal-title":"J Pharmacol Exp Ther"},{"key":"10.4065\/75.7.711_bib15","first-page":"67","article-title":"Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine","volume":"21","author":"Taylor","year":"1978","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.4065\/75.7.711_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0024-3205(79)90126-7","article-title":"The central stimulatory action of inhibitors oi the dopamine uptake","volume":"24","author":"Ross","year":"1979","journal-title":"Life Sci"},{"key":"10.4065\/75.7.711_bib17","first-page":"1062","article-title":"[3H]Threo-)-methylphenidate binding (o 3,4-dihydroxyphenylelhylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters","volume":"45","author":"Schweri","year":"1985","journal-title":"\/Neurmhem"},{"key":"10.4065\/75.7.711_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0014-2999(85)90724-1","article-title":"The effects of surgical and chemical lesions on striatal [3H]hreo-(\u00b1)-methylphenidate binding: correlation with ['HJdopaminc uptake","volume":"108","author":"Janowsky","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.4065\/75.7.711_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(89)90066-6","article-title":"In vivo ncurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen","volume":"166","author":"Hurd","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.4065\/75.7.711_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0304-3940(91)90869-U","article-title":"Characterisation of methylphenidate and nomifensinc induced dopamine release in rat striatum using in vivo brain microdialysis","volume":"122","author":"Butcher","year":"1991","journal-title":"Neurosci Let"},{"key":"10.4065\/75.7.711_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0026-895X(25)08574-8","article-title":"Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux","volume":"47","author":"Wall","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.4065\/75.7.711_bib22","series-title":"Goodman & Cilman's The Pharmacological Basis of Therapeutics","first-page":"220","article-title":"Catecholammes. sympathomimetic drugs, and adrenergic receptor antagonists","author":"Hoffman","year":"1996"},{"key":"10.4065\/75.7.711_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0165-0173(97)00063-5","article-title":"Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis","volume":"26","author":"Gainetdinov","year":"1998","journal-title":"Brain Res Brain Res Rev"},{"key":"10.4065\/75.7.711_bib24","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1176\/ajp.155.10.1325","article-title":"Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate","volume":"155","author":"Volkow","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.4065\/75.7.711_bib25","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1126\/science.1948034","article-title":"Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA [published correction appears in Science. 1992; 255:1195]","volume":"254","author":"Shimada","year":"1991","journal-title":"Science"},{"key":"10.4065\/75.7.711_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0169-328X(92)90165-8","article-title":"A human dopamine transporter cDNA predicts reduced glycosylation. displays a novel repetitive element and provides racially-dimorphic Taq R FLPs","volume":"15","author":"Vandenbergh","year":"1992","journal-title":"Brain Res Mol Brain Res"},{"key":"10.4065\/75.7.711_bib27","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0888-7543(05)80138-7","article-title":"Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR","volume":"14","author":"Vandenbergh","year":"1992","journal-title":"Genomics"},{"key":"10.4065\/75.7.711_bib28","first-page":"993","article-title":"Association of attention-deficit disorder and the dopamine transporter gene","volume":"56","author":"Cook","year":"1995","journal-title":"Am J Hum Genel"},{"key":"10.4065\/75.7.711_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.mp.4000290","article-title":"Confirmation of association between attention deficit hypcractivity disorder and a dopamine transporter polymorphism","volume":"2","author":"Gill","year":"1997","journal-title":"Mol Psychiatry"},{"key":"10.4065\/75.7.711_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0014-2999(85)90364-4","article-title":"Autoradiographic localization of [3]methylphenidate binding sites in rat brain","volume":"113","author":"Unis","year":"1985","journal-title":"EurJ Pharmacol"},{"key":"10.4065\/75.7.711_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(90)91719-W","article-title":"Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum. nucleus accumbens. olfactory tubercle, and medial prefrontal cortex","volume":"520","author":"Izenwasser","year":"1990","journal-title":"Brain Res"},{"key":"10.4065\/75.7.711_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0006-8993(91)91220-U","article-title":"Exogenous tyrosine potentiates the methylphenidate-induced increase in extracellular dopamine in the nucleus accumbens: a microdialysis study","volume":"56","author":"Woods","year":"1991","journal-title":"Brain Res"},{"key":"10.4065\/75.7.711_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3940(92)90698-7","article-title":"Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex","volume":"140","author":"During","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.4065\/75.7.711_bib34","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1023\/A:1012186519946","article-title":"IgaT. Pharmaco-dynamic modeling for change of locomotor activity by methylphenidate in rats","volume":"14","author":"Aoyama","year":"1997","journal-title":"Pharm Res"},{"key":"10.4065\/75.7.711_bib35","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1471-4159.1997.68052032.x","article-title":"Effects of methylphenidate on extracellular dopamine, serotonin, and norcpinephrine: comparison with amphetamine [published correction appears in J Neumchem. 1997;69:1332)","volume":"68","author":"Kuczenski","year":"1997","journal-title":"J Neurochcm"},{"key":"10.4065\/75.7.711_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1054-3589(08)60730-9","article-title":"Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates","volume":"42","author":"Volkow","year":"1998","journal-title":"Adv Pharmacol"},{"key":"10.4065\/75.7.711_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/syn.890180207","article-title":"Pharmacokinetics and in vivo specificity of [CJt\u00edf-rfl\u00ede\u00edJ-melhylphcnidatc for the presyn-aplic dopammergic neuron","volume":"18","author":"Ding","year":"1994","journal-title":"Synapse"},{"key":"10.4065\/75.7.711_bib38","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archpsyc.1995.03950180042006","article-title":"Is methylphenidate like cocaine? studies on their pharmacokinetics and distribution in the human brain","volume":"52","author":"Volkow","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.4065\/75.7.711_bib39","first-page":"422","article-title":"Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of\/-I'HJnorepincphrine and ['Hldopaminc by synaptic vesicles from rat whole brain, strialum and hypothalamus","volume":"210","author":"Ferris","year":"1979","journal-title":"Pharmacol ExpTher"},{"key":"10.4065\/75.7.711_bib40","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","article-title":"Cocaine receptors on dopamine transporters arc related to self-administration of cocaine","volume":"237","author":"Ritz","year":"1987","journal-title":"Science"},{"key":"10.4065\/75.7.711_bib41","first-page":"231","article-title":"Affinities of methylphenidate derivatives for dopamine, norepinephrinc and serotonin transporters","volume":"58","author":"Galley","year":"1996","journal-title":"Life Sei"},{"key":"10.4065\/75.7.711_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF02246277","article-title":"Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects","volume":"123","author":"Volkow","year":"1996","journal-title":"Psychophar-macology (Bert)"},{"key":"10.4065\/75.7.711_bib43","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hypcrlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"key":"10.4065\/75.7.711_bib44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.283.5400.397","article-title":"Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity","volume":"283","author":"Gaincldinov","year":"1999","journal-title":"Science"},{"key":"10.4065\/75.7.711_bib45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0022-3565(25)30016-9","article-title":"Metabolism and disposition of methylphenidate-IJC: studies in man and animals","volume":"191","author":"Faraj","year":"1974","journal-title":"J Pharmacol Exp Ther"},{"key":"10.4065\/75.7.711_bib46","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0090-9556(25)07963-2","article-title":"A study of methylphenidate in man with respect to its major metabolite","volume":"10","author":"Redalieu","year":"1982","journal-title":"Drug Metab Dispos"},{"key":"10.4065\/75.7.711_bib47","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1542\/peds.69.6.688","article-title":"Psychophamiacology of attention deficit disorder: pharmacokinctic. ncuroendocrinc, and behavioral measures following acute and chronic treatment with methylphenidate","volume":"69","author":"Shaywilz","year":"1982","journal-title":"Pediatrics"},{"key":"10.4065\/75.7.711_bib48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0022-3565(25)21542-7","article-title":"Pharmacokinetics of methylphenidate in man, rat and monkey","volume":"226","author":"Wargin","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.4065\/75.7.711_bib49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1542\/peds.72.1.56","article-title":"Methylphenidate hydrochloride given with or before breakfast, II: effects on plasma concentration of methylphenidate and ritalinic acid","volume":"72","author":"Chan","year":"1983","journal-title":"Pediatrics"},{"key":"10.4065\/75.7.711_bib50","first-page":"69","article-title":"Pharmacological factors of methylphenidate metabolism in behaviorally disordered children","volume":"16","author":"Winsberg","year":"1980","journal-title":"Psychopharmacol Bull"},{"key":"10.4065\/75.7.711_bib51","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2125.1979.tb01046.x","article-title":"Pharmacokinetics of methylphenidate in hyperkinetic children","volume":"8","author":"Hungund","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.4065\/75.7.711_bib52","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/j.1552-4604.1998.tb04425.x","article-title":"Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers","volume":"38","author":"Wong","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.4065\/75.7.711_bib53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00315285","article-title":"Nonlinear kinetics of \/Areo-mcthylphcnidate cnantiomers in a patient with narcolepsy and in healthy volunteers","volume":"44","author":"Aoyama","year":"1993","journal-title":"Fur J Clin Pharmacol"},{"key":"10.4065\/75.7.711_bib54","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jps.2600790602","article-title":"Kinetic analysis of cnantiomers of co-methylphenidate and ils metabolite in two healthy subjects after oral administration as determined by a gas chromatographic-mass spectrometric method","volume":"79","author":"Aoyama","year":"1990","journal-title":"J Pharm Set"},{"key":"10.4065\/75.7.711_bib55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1023\/A:1018956526016","article-title":"Enantioselective pharmacokinetics of rt-al-threo-methylplienidatc in humans","volume":"10","author":"Snnivas","year":"1993","journal-title":"Pharm Res"},{"key":"10.4065\/75.7.711_bib56","first-page":"97","article-title":"Sustained-release methylphenidate","volume":"26","year":"1984","journal-title":"Med cit Drugs Ther"},{"key":"10.4065\/75.7.711_bib57","first-page":"51","volume":"30","author":"Methylphenidate revisited","year":"1988","journal-title":"Med Lett Drugs Ther"},{"key":"10.4065\/75.7.711_bib58","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/jps.2600781113","article-title":"Enantio-selective aspects of the disposition of \u00ed\u00ed\u00ed-rftrpw-methylphenidate after the administration of a sustained-release formulation to children with attention dcficil-hypcraciivity disorder","volume":"78","author":"Hubbard","year":"1989","journal-title":"J Pharm Sci"},{"key":"10.4065\/75.7.711_bib59","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00004583-198909000-00020","article-title":"Sustained release methylphenidate: pharmacokinetic studies in ADDH males","volume":"28","author":"Birmaher","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.4065\/75.7.711_bib60","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1177\/106002809703101001","article-title":"Effect on dissolution from halving methylphenidate extended-release tablets","volume":"31","author":"Erramouspe","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.4065\/75.7.711_bib61","first-page":"525","article-title":"Slow-release methylphenidate: problems when children chew tablets [letter]","volume":"45","author":"Rosse","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib62","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-5347(25)00340-4","article-title":"Pharmacology of the enantiomers of threo-methylphenidate","volume":"241","author":"Patrick","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.4065\/75.7.711_bib63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/clpt.1992.185","article-title":"Enanlio-seleclive pharmacokinetics and pharmacodynamics of dl-threo-methylphenidale in children with attention deficit hyperactivity disorder","volume":"52","author":"Srinivas","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.4065\/75.7.711_bib64","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1023\/A:1018917205292","article-title":"Stereospecific distribution of methylphenidate enantiomers in rat brain: specific binding to dopamine reuptake sites","volume":"11","author":"Aoyama","year":"1994","journal-title":"Pharm Res"},{"key":"10.4065\/75.7.711_bib65","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02805984","article-title":"Pharmacokinetics and pharmacodynamics of methylphenidate cnantiomers in rats","volume":"I27","author":"Aoyama","year":"1996","journal-title":"Psy-chopharmacology (Berl)"},{"key":"10.4065\/75.7.711_bib66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0165-1781(97)00138-8","article-title":"Differences in plasma concentrations of the D- and L-threo methylphenidate enantiomers in responding and non-responding children with attention-deficit hyperactivity disorder","volume":"78","author":"Jonkman","year":"1998","journal-title":"Psychiatry Res"},{"key":"10.4065\/75.7.711_bib67","series-title":"Celgene Corporation announces launch of Canadian clinical trial program for chirally pure version of Ritalin(R) [press release]","year":"1999"},{"key":"10.4065\/75.7.711_bib68","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0002-9343(98)00193-4","article-title":"Contrasting actions of prcssor agents in severe autonomic failure","volume":"05","author":"Jordan","year":"1998","journal-title":"Am J Med"},{"key":"10.4065\/75.7.711_bib69","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0022-5347(01)65776-8","article-title":"Successful treatment of giggle incontinence with methylphenidate","volume":"156","author":"Sher","year":"1996","journal-title":"y Urol"},{"key":"10.4065\/75.7.711_bib70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-3999(94)00075-G","article-title":"Methylphenidate in the \u201chard to wean\u201d patient","volume":"39","author":"Johnson","year":"1995","journal-title":"J Psychosom Res"},{"key":"10.4065\/75.7.711_bib71","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/ajp.94.3.577","article-title":"Behavior of children receiving benzedrine","volume":"94","author":"Bradley","year":"1937","journal-title":"Am J Psychiatry"},{"key":"10.4065\/75.7.711_bib72","series-title":"Diagnostic and Statistical Manual of Mental Disorders","first-page":"78","author":"American Psychiatric Association","year":"1994"},{"key":"10.4065\/75.7.711_bib73","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00004583-200002000-00018","article-title":"National Institutes of Health Consensus Development Conference Statement; diagnosis and treatment of attention-deficit\/hyperactivity disorder (ADHD)","volume":"39","year":"2000","journal-title":"J Am Acad Child Adolesc Psychia-try"},{"key":"10.4065\/75.7.711_bib74","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0193-953X(18)30265-X","article-title":"The stimulants","volume":"15","author":"Wilens","year":"1992","journal-title":"Psychiatr Clin North Am"},{"key":"10.4065\/75.7.711_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0193-953X(18)30255-7","article-title":"Pharmacologie treatment of attention deficit hypcr-aclivity disorder","volume":"15","author":"Grccnhill","year":"1992","journal-title":"Psychiatr Clin North Am"},{"key":"10.4065\/75.7.711_bib76","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/001440299306000209","article-title":"Effect of stimulant medication on children with attention deficit disorder: a \u201creview of reviews.\u201d","volume":"60","author":"Swanson","year":"1993","journal-title":"Except Child"},{"key":"10.4065\/75.7.711_bib77","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0065-3101(24)00056-2","article-title":"Attcntion-deficit\/hy-pcractivity disorder","volume":"44","author":"Shaywiiz","year":"1997","journal-title":"Adv Pediatr"},{"key":"10.4065\/75.7.711_bib78","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF02179289","article-title":"Use of methy Iphenidale in the treatment of children with autistic disorder","volume":"25","author":"Quintana","year":"1995","journal-title":"J Autism Dei-Disord"},{"key":"10.4065\/75.7.711_bib79","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/088307389701200405","article-title":"Treatment of children with Williams syndrome with methylphenidate","volume":"12","author":"Bawdcn","year":"1997","journal-title":"J Child Neural"},{"key":"10.4065\/75.7.711_bib80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1025873206116","article-title":"Brief report: response lo methylphenidate in two children with Williams syndrome","volume":"27","author":"Power","year":"1997","journal-title":"J Autism Dev Disord"},{"key":"10.4065\/75.7.711_bib81","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1176\/ajp.155.9.1265","article-title":"Pradcr-Willi syndrome","volume":"155","author":"Martin","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.4065\/75.7.711_bib82","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00004583-198909000-00019","article-title":"Treatment of ADDH in mentally retarded children: a preliminary study","volume":"28","author":"Paylon","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.4065\/75.7.711_bib83","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1542\/peds.86.6.922","article-title":"Efficacy of methylphenidate among menially retarded children with attention deficit hyperaclivity disorder","volume":"86","author":"Handen","year":"1990","journal-title":"Pediatrics"},{"key":"10.4065\/75.7.711_bib84","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00004583-199103000-00013","article-title":"Clinical effects of methylphenidate and thioridazine in intellectually subaverage children","volume":"30","author":"Aman","year":"1991","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.4065\/75.7.711_bib85","first-page":"816","article-title":"Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance","volume":"30","author":"Aman","year":"1991","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.4065\/75.7.711_bib86","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004583-199205000-00011","article-title":"Effects and noneffects of methylphenidate in children with mental retardation and ADHD","volume":"31","author":"H\u00e4nden","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.4065\/75.7.711_bib87","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/01454455940184005","article-title":"Efficacy of methylphenidate and behavioral intervention on classroom behavior in children with ADHD and mental retardation","volume":"18","author":"Johnson","year":"1994","journal-title":"Behav Modif"},{"key":"10.4065\/75.7.711_bib88","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00004583-199410000-00014","article-title":"Prediction of response to methylphenidate among children with ADHD and mental retardation","volume":"33","author":"Handen","year":"1994","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.4065\/75.7.711_bib89","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1901\/jaba.1996.29-305","article-title":"Separate and combined effects of methylphenidate and a behavioral intervention on disruptive behavior in children with mental retardation","volume":"29","author":"Blum","year":"1996","journal-title":"J Appl Behav Anal"},{"key":"10.4065\/75.7.711_bib90","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/A:1025760302598","article-title":"Long-term follow-up of children with mental retardation\/borderline intellectual functioning and ADHD","volume":"25","author":"Handen","year":"1997","journal-title":"J Abnorm Child Psycho"},{"key":"10.4065\/75.7.711_bib91","first-page":"282","article-title":"Comparison of sustained release and standard methylphenidate in the treatment of minimal brain dysfunction","volume":"41","author":"Whitchouse","year":"1980","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib92","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1542\/peds.86.2.226","article-title":"Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemolinc","volume":"86","author":"Pelham","year":"1990","journal-title":"Pediatrics"},{"key":"10.4065\/75.7.711_bib93","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00004583-199203000-00008","article-title":"Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder","volume":"31","author":"Fitzpatrick","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.4065\/75.7.711_bib94","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1542\/peds.80.4.491","article-title":"Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder","volume":"80","author":"Pelham","year":"1987","journal-title":"Pediatrics"},{"issue":"suppl 7","key":"10.4065\/75.7.711_bib95","first-page":"76","article-title":"Pharmacotherapy of attention-deficithyperactivity disorder in adults","volume":"59","author":"Wender","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib96","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archpsyc.1976.01770120057005","article-title":"Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report","volume":"33","author":"Wood","year":"1976","journal-title":"Arch Gen Psychiatry"},{"key":"10.4065\/75.7.711_bib97","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archpsyc.1983.01790220049008","article-title":"Methylphenidate effects on symptoms or attention deficit disorder in adults","volume":"41","author":"Mattes","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"10.4065\/75.7.711_bib98","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00002826-198512000-00005","article-title":"Attention deficit disorders in adults","volume":"8","author":"Gualtieri","year":"1985","journal-title":"Clin Neuropharmacol"},{"key":"10.4065\/75.7.711_bib99","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1176\/ajp.142.5.547","article-title":"A control led study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults","volume":"142","author":"Wender","year":"1985","journal-title":"Am J Psychiatry"},{"key":"10.4065\/75.7.711_bib100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/archpsyc.1995.03950180020004","article-title":"A double-bl i nd, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperaclivity disorder","volume":"52","author":"Spencer","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.4065\/75.7.711_bib101","first-page":"288","article-title":"Long-term treatment of narcolepsy with methylphenidate (Ritalin(r))","volume":"25","author":"Honda","year":"1979","journal-title":"Curr Ther Res Clin exp"},{"key":"10.4065\/75.7.711_bib102","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/sleep\/9.1.260","article-title":"Treatment of narcolepsy: objective studies on methylphenidate, pemolinc, and protriptyline","volume":"9","author":"Mitler","year":"1986","journal-title":"Sleep"},{"key":"10.4065\/75.7.711_bib103","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00004691-199001000-00008","article-title":"Narcolepsy","volume":"7","author":"Mitler","year":"1990","journal-title":"J Clin Neurophysiol"},{"key":"10.4065\/75.7.711_bib104","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/jnnp.21.1.55","article-title":"A controlled trial of methyl phenidate (Ritalin) in the treatment of depressive states","volume":"21","author":"Robin","year":"1958","journal-title":"J NeurolNeurosurg Psychiatry"},{"key":"10.4065\/75.7.711_bib105","first-page":"1249","article-title":"Depressive states and drugs, 111: use of methylphenidate (Ritalin) in open psychiatric sellings and in office practice","volume":"83","author":"Kerenyi","year":"1960","journal-title":"Can Med Assoc J"},{"key":"10.4065\/75.7.711_bib106","first-page":"241","article-title":"Stimulants in the treatment of depression; a critical overview","volume":"50","author":"Satcl","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib107","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0033-3182(95)71619-X","article-title":"Scrtraline with methylphenidate in an ICU patient [IcttcrJ","volume":"36","author":"McGlohn","year":"1995","journal-title":"Psychosomatics"},{"key":"10.4065\/75.7.711_bib108","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00004714-199104000-00010","article-title":"CNS stimulant potcntiation of monoaminc oxidase inhibitors in treatment-refractory depression","volume":"11","author":"Fawcett","year":"1991","journal-title":"J Clin Psychopharmacol"},{"key":"10.4065\/75.7.711_bib109","first-page":"72","article-title":"Methyl phenidate augmentation of serotonin selective reuptake inhibitors: a case series","volume":"57","author":"Sloll","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00004714-199806000-00014","article-title":"Venlafaxine augmentation with methylphenidate for treatment-refractory depression: a case report [letter]","volume":"18","author":"Bader","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.4065\/75.7.711_bib111","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/00048679709073843","article-title":"A review of the use of augmentation therapy for the treatment of resistant depression: implications for the clinician [published correction appears in Aust N Z J Psychiatry. 1997;31:787]","volume":"31","author":"Schweitzer","year":"1997","journal-title":"Aust N Z J Psychiatry"},{"key":"10.4065\/75.7.711_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2190\/2TVT-2LH0-AD5A-CP91","article-title":"Medical use of psychostimulants: an overview","volume":"25","author":"Holmes","year":"1995","journal-title":"Int J Psychiatry Med"},{"key":"10.4065\/75.7.711_bib113","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/106002809603000209","article-title":"SemlaTP. Depression in the medically ill elderly: a focus on methylphenidate","volume":"30","author":"Emptage","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.4065\/75.7.711_bib114","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.1959.03000320041011","article-title":"Double-blind evaluation of methylphenidate (Ritalin) hydrochloride: its use in the management of institutionalized geriatric patients","volume":"169","author":"Darvill","year":"1959","journal-title":"JAMA"},{"key":"10.4065\/75.7.711_bib115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1532-5415.1960.tb00108.x","article-title":"A stimulant for the aged: observations on a melhylphenidate vilamin hormone combination (Ritonic)","volume":"8","author":"Bare","year":"1960","journal-title":"J Am Geriatr Soc"},{"key":"10.4065\/75.7.711_bib116","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1532-5415.1962.tb00520.x","article-title":"A stimulant for the aged, II: long-term observations with a melhylphenidale-vitamin-hormonc combination (Rilonic)","volume":"10","author":"Bare","year":"1962","journal-title":"J Am Geriatr Soc"},{"key":"10.4065\/75.7.711_bib117","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1532-5415.1975.tb00317.x","article-title":"Withdrawn, apathetic geriatric patients responsive to melhylphenidate","volume":"23","author":"Kaplitz","year":"1975","journal-title":"J Am Geriatr Soc"},{"key":"10.4065\/75.7.711_bib118","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00426708","article-title":"The effect of melhylphenidate on lesl performance in the cognitively impaired aged","volume":"52","author":"Crook","year":"1977","journal-title":"P' sychopharmacology (Berlj"},{"key":"10.4065\/75.7.711_bib119","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1176\/ajp.137.8.963","article-title":"Treatment of depression in the medically ill elderly with melhylphenidate","volume":"137","author":"Katon","year":"1980","journal-title":"Am J Psychiatry"},{"key":"10.4065\/75.7.711_bib120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/070674378402900112","article-title":"Use of psychoslimulants in medically ill patients with neurological disease and major depression","volume":"29","author":"Kaufmann","year":"1984","journal-title":"Can J Psychiatry"},{"key":"10.4065\/75.7.711_bib121","first-page":"82","article-title":"The use of melhylphenidate in depressed patients after cardiac surgery","volume":"45","author":"Kaufmann","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib122","first-page":"467","article-title":"Elderly depressed females as a possible subgroup of patients responsive to melhylphenidate","volume":"47","author":"Askinazi","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib123","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0033-3182(91)72093-8","article-title":"Psychoslimulants for secondary depression in medical illness","volume":"32","author":"Masand","year":"1997","journal-title":"Psychosomaticl"},{"key":"10.4065\/75.7.711_bib124","first-page":"263","article-title":"Melhylphenidate in depressed medically ill patients","volume":"52","author":"Rosenberg","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib125","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1176\/ajp.152.6.929","article-title":"Double-blind, placebo-controlled trial of melhylphenidate in older, depressed, medically ill palicnis","volume":"152","author":"Wallace","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.4065\/75.7.711_bib126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1176\/jnp.7.1.23","article-title":"Apathy: a treatable syndrome","volume":"7","author":"Marin","year":"1995","journal-title":"J Neuropsychiatre Clin Newosci"},{"key":"10.4065\/75.7.711_bib127","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1176\/jnp.9.2.231","article-title":"Melhylphenidate treatment of negative symptoms in patients with dementia","volume":"9","author":"Galynker","year":"1997","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.4065\/75.7.711_bib128","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0033-3182(98)71358-1","article-title":"Melhylphenidate in post liver transplant patients","volume":"39","author":"Plutchik","year":"1998","journal-title":"Psychosomat-ics"},{"key":"10.4065\/75.7.711_bib129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2190\/BXRM-3M58-WBC5-A7EL","article-title":"Neuropsychiatrie sequelae of stroke and traumatic brain injury: the role of psychoslimulants","volume":"25","author":"Kraus","year":"1995","journal-title":"Int J Psychiatry Med"},{"key":"10.4065\/75.7.711_bib130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00005053-198702000-00007","article-title":"Treatment of chronic closed head injury with psychostimulant drugs: a controlled case study and an appropriate evaluation procedure","volume":"175","author":"Evans","year":"1987","journal-title":"J Nerv Ment Dis"},{"key":"10.4065\/75.7.711_bib131","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/02699058809150898","article-title":"Stimulant treatment for the ncuro-behavioural sequelae of traumatic brain injury","volume":"2","author":"Gualtieri","year":"1988","journal-title":"Brain Inj"},{"key":"10.4065\/75.7.711_bib132","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0003-9993(96)90291-9","article-title":"Subacute melhylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study","volume":"77","author":"Plenger","year":"1996","journal-title":"Arch Phys Med Re habt I"},{"key":"10.4065\/75.7.711_bib133","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00002060-199711000-00002","article-title":"Effects of melhylphenidate on attentional function after traumatic brain injury: a randomized, placebo-controlled trial","volume":"76","author":"Whyte","year":"1997","journal-title":"Am J Phys Med Rehabil"},{"key":"10.4065\/75.7.711_bib134","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/02699059309034959","article-title":"A double-blind controlled study of melhylphenidate treatment in closed head injury","volume":"7","author":"Speech","year":"1993","journal-title":"Brain Inj"},{"key":"10.4065\/75.7.711_bib135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001199-199806000-00007","article-title":"Recovery in p\u00e9diatrie brain injury: is psychostimulant medication beneficial?","volume":"13","author":"Williams","year":"1998","journal-title":"J Head Trauma Rehabil"},{"key":"10.4065\/75.7.711_bib136","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0003-9993(96)90211-7","article-title":"Melhylphenidate effect on attention deficit in the acutely brain-injured adult","volume":"77","author":"Kaclin","year":"1996","journal-title":"Arch Phys Med Rehabil"},{"key":"10.4065\/75.7.711_bib137","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/17518429709060937","article-title":"The use of melhylphenidate in pacdiatric traumatic brain injury","volume":"1","author":"Hornyak","year":"1997","journal-title":"Pediatr Rehabil"},{"key":"10.4065\/75.7.711_bib138","first-page":"495","article-title":"Melhylphenidate in the treatment of coma","volume":"44","author":"Worzniak","year":"1997","journal-title":"J Fam Pracl"},{"key":"10.4065\/75.7.711_bib139","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00002060-199601000-00016","article-title":"Successful treatment of post-traumatic narcolepsy wilh melhylphenidate: a case report","volume":"75","author":"Francisco","year":"1996","journal-title":"Am J Phys Med Rehabil"},{"key":"10.4065\/75.7.711_bib140","first-page":"153","article-title":"Effect of mcthylphenidatc on brain injury-related anger","volume":"74","author":"Mooney","year":"1993","journal-title":"Arch Phys Med Rehabil"},{"key":"10.4065\/75.7.711_bib141","first-page":"86","article-title":"Methylphenidatc and seizure frequency in brain injured patients with seizure disorders","volume":"53","author":"Wroblewski","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib142","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0003-9993(98)90019-3","article-title":"Neuropharmaeologic treatment of hemineglect: a case report comparing bromocriptine and melhylphenidate","volume":"79","author":"Hurford","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"key":"10.4065\/75.7.711_bib143","first-page":"151","article-title":"Melhylphenidate in treating poststroke depression","volume":"49","author":"Iingam","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib144","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00002060-199208000-00008","article-title":"Methylphenidatc in stroke patients wilh depression","volume":"71","author":"Johnson","year":"1992","journal-title":"Am J Phys Med Rehabil"},{"key":"10.4065\/75.7.711_bib145","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0003-9993(94)90163-5","article-title":"Melhylphenidate and nortriptyline in the treatment of poststroke depression: a retrospective comparison","volume":"75","author":"Lazarus","year":"1994","journal-title":"Arch Phys Med Rehabil"},{"key":"10.4065\/75.7.711_bib146","first-page":"447","article-title":"Efficacy and side effects of mcthylphenidale for poststroke depression","volume":"53","author":"Lazarus","year":"1992","journal-title":"1 Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib147","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0003-9993(98)90169-1","article-title":"Mcthylphenidale in early poststroke recovery: a double-blind, placebo-controlled study","volume":"79","author":"Grade","year":"1998","journal-title":"Arch Phys Med Rehabil"},{"key":"10.4065\/75.7.711_bib148","first-page":"25","article-title":"Diagnosis and treatment of depression in the cancer patient","volume":"45","author":"Massie","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib149","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archpsyc.1995.03950140007002","article-title":"Depression in patients with cancer: diagnosis, biology, and treatment","volume":"52","author":"McDaniel","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.4065\/75.7.711_bib150","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0033-3182(90)72145-7","article-title":"Long-term methylphenidate use in the medically ill patient wilh organic mood syndrome","volume":"31","author":"Stiebe","year":"1990","journal-title":"Psychosomatics"},{"key":"10.4065\/75.7.711_bib151","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0885-3924(94)00080-5","article-title":"Mcthylphenidate for the management of somalizalion in terminal cancer patients","volume":"10","author":"Vigano","year":"1995","journal-title":"j Pain Symptom Manage"},{"key":"10.4065\/75.7.711_bib152","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hed.2890080410","article-title":"Methylphenidate treatment of patients with head and neck cancer","volume":"8","author":"Fernandez","year":"1986","journal-title":"Head Neck Surg"},{"key":"10.4065\/75.7.711_bib153","first-page":"455","article-title":"Methylphenidatc for depressive disorders in cancer patients: an alternative to standard antidepressants","volume":"28","author":"Fernandez","year":"1987","journal-title":"PiyeAfMomiWes"},{"key":"10.4065\/75.7.711_bib154","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0033-3182(96)71599-2","article-title":"Psychostimulants for depression in hospitalized cancer patients","volume":"37","author":"Olin","year":"1996","journal-title":"Psychosomatics"},{"key":"10.4065\/75.7.711_bib155","first-page":"193","article-title":"Methylphenidate in terminal depression","volume":"16","author":"Macleod","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.4065\/75.7.711_bib156","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1176\/jnp.7.3.347","article-title":"Methylphenidate in the treatment of ncurobehavioral slowing associated with cancer and cancer treatment","volume":"7","author":"Weitzner","year":"1995","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.4065\/75.7.711_bib157","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.1998.16.7.2522","article-title":"Methylphenidate therapy improves cognition, mood. and function of brain tumor patients","volume":"16","author":"Meyers","year":"1998","journal-title":"J Clm Oncol"},{"key":"10.4065\/75.7.711_bib158","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/088307389200700425","article-title":"Mcthylphcnidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia [letter]","volume":"7","author":"Delong","year":"1992","journal-title":"J Child Nenrol"},{"key":"10.4065\/75.7.711_bib159","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0885-3924(98)00085-2","article-title":"Psychostiulant drugs potentiate morphine analgesia in the formalin test","volume":"16","author":"Dalai","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.4065\/75.7.711_bib160","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0885-3924(98)00084-0","article-title":"Potentiation of opioid analgesia by psycho-stimulant drugs: a review","volume":"16","author":"Dalat","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.4065\/75.7.711_bib161","first-page":"67","article-title":"Methylphenidate associated with narcotics for the treatment of cancer pain","volume":"71","author":"Bruera","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"10.4065\/75.7.711_bib162","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00365854","article-title":"A randomized, crossover evaluation of melhylphenidate in cancer patients receiving strong narcotics","volume":"3","author":"Wilwerding","year":"1995","journal-title":"Support Care Cancer"},{"key":"10.4065\/75.7.711_bib163","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0885-3924(89)90057-2","article-title":"Use of mcthylphcnidate as an adjuvant to narcotic analgesics in patients with advanced cancer, \/","volume":"4","author":"Bruera","year":"1989","journal-title":"Pain Symptom Manage"},{"key":"10.4065\/75.7.711_bib164","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0304-3959(92)90114-Q","article-title":"The use of melhylphenidate in patients with incident cancer pain receiving regular opiates: a preliminary report","volume":"50","author":"Bruera","year":"1992","journal-title":"Pain"},{"key":"10.4065\/75.7.711_bib165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-3959(92)90053-E","article-title":"Neuropsycho-togical effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain","volume":"48","author":"Bruera","year":"1992","journal-title":"Pain"},{"key":"10.4065\/75.7.711_bib166","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0885-3924(94)90165-1","article-title":"Bcrde Cfi. Dextroamphctaminc or mcthylphcnidate as adjuvants to opioid analgesia for adolescents with cancer","volume":"9","author":"Yee","year":"1994","journal-title":"J Pain Symptom Manage"},{"key":"10.4065\/75.7.711_bib167","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2190\/72U2-FQ94-RVK5-6J5C","article-title":"The use of methylphenidate for cognitive decline associated with HIV disease","volume":"25","author":"Brown","year":"1995","journal-title":"int J Psychiatry Med"},{"key":"10.4065\/75.7.711_bib168","first-page":"628","article-title":"Response of HIV-related depression to psychostimulants; case reports","volume":"39","author":"Fernandez","year":"1988","journal-title":"Hosp Community Psychiatry"},{"key":"10.4065\/75.7.711_bib169","first-page":"195","article-title":"The use of methylphenidate in a depressed adolescent with AIDS","volume":"71","author":"Walling","year":"1990","journal-title":"JDev Behav Pediatr"},{"key":"10.4065\/75.7.711_bib170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0033-3182(88)72420-2","article-title":"Cognitive impairment due to AIDS-related complex and its response to psychostimulants","volume":"29","author":"Fernandez","year":"1988","journal-title":"Psychosomaiics"},{"key":"10.4065\/75.7.711_bib171","first-page":"5","article-title":"Psychostimulant response in AIDS-related complex patients","volume":"50","author":"Holmes","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib172","first-page":"268","article-title":"Central nervous system stimulants as symptomatic treatments lor AIDS-related neuropsychiatrie impairment","volume":"12","author":"Angrist","year":"1992","journal-title":"J Clin Psychopharmacoi"},{"key":"10.4065\/75.7.711_bib173","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2190\/16FH-9ECT-Y280-VV45","article-title":"Effects of methylphenidate in HIV-relaled depression: a comparative trial with desi-praminc","volume":"25","author":"Fernandez","year":"1995","journal-title":"int J Psychiatry Med"},{"key":"10.4065\/75.7.711_bib174","first-page":"153","article-title":"Methylphenidate as a treatment for depression in acquired immunodeficiency syndrome: an n-of-1 trial","volume":"53","author":"White","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.4065\/75.7.711_bib175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1176\/jnp.9.1.29","article-title":"Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot study","volume":"9","author":"van Dyck","year":"1997","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.4065\/75.7.711_bib176","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archpsyc.1988.01800360075011","article-title":"Methylphenidate and growth in hyperactive children: a controlled withdrawal study","volume":"45","author":"Klein","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.4065\/75.7.711_bib177","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archpsyc.1988.01800360079012","article-title":"Hyperactive boys almost grown up. III melhylphenidate effects on ultimate height","volume":"45","author":"Klein","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.4065\/75.7.711_bib178","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1176\/ajp.147.4.501","article-title":"Effects of methylphenidate on early adolescent growth","volume":"147","author":"Vincent","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.4065\/75.7.711_bib179","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/00004583-199611000-00014","article-title":"Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?","volume":"35","author":"Spencer","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.4065\/75.7.711_bib180","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.1982.03320370043028","article-title":"Stimulant medications precipitate Tourelte's syndrome","volume":"247","author":"Lowe","year":"1982","journal-title":"JAMA"},{"key":"10.4065\/75.7.711_bib181","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archpsyc.56.4.330","article-title":"Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder","volume":"56","author":"Gadow","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.4065\/75.7.711_bib182","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/00004583-199908000-00009","article-title":"Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?","volume":"38","author":"Law","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.4065\/75.7.711_bib183","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.1991.00400040119027","article-title":"Intravenous methylphenidate abuse: prototype for prescription drug abuse","volume":"151","author":"Parran","year":"1991","journal-title":"Arch intern Med"},{"key":"10.4065\/75.7.711_bib184","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1520\/JFS14440J","article-title":"A fatality due to the intranasal abuse of methylphenidate (Ritalin)","volume":"44","author":"Massello","year":"1999","journal-title":"J Forensic Sei"},{"key":"10.4065\/75.7.711_bib185","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00004583-199806000-00006","article-title":"Intranasal abuse of prescribed methylphenidate (Ict-erj","volume":"37","author":"Garland","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.4065\/75.7.711_bib186","doi-asserted-by":"crossref","first-page":"PL7","DOI":"10.1016\/S0024-3205(99)00225-8","article-title":"Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain","volume":"65","author":"Volkow","year":"1999","journal-title":"Life Sei"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611646181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611646181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T05:57:21Z","timestamp":1738907841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611646181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":186,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S0025619611646181"],"URL":"https:\/\/doi.org\/10.4065\/75.7.711","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}